• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Flyte Partners with GSE Worldwide and PGA TOUR Professional Emiliano Grillo, Debuted at the 2026 U.S. Open

    6/22/26 4:15:00 PM ET
    $VTAK
    Medical/Dental Instruments
    Health Care
    Get the next $VTAK alert in real time by email

    Partnership positions Flyte within elite professional sports ecosystem through leading talent agency GSE Worldwide

    Collaboration highlights growing demand for efficient regional travel solutions among professional athletes

    FORT MILL, S.C., June 22, 2026 (GLOBE NEWSWIRE) -- Flyte, the rapidly growing Regional Air Mobility subsidiary of Catheter Precision, Inc. (NYSE:VTAK), today announced a partnership with sports and entertainment agency GSE Worldwide and PGA TOUR professional Emiliano Grillo that began this past weekend in the U.S. Open Championship.

    Grillo delivered an impressive performance at the 2026 U.S. Open, climbing as high as third place on the leaderboard during the championship. His strongest round came on Saturday, when he carded a 3-under-par 67 in challenging windy conditions, positioning himself firmly in contention heading into the final round. Grillo ultimately finished tied for 23rd in one of golf's most competitive major championships.

    The partnership represents a significant milestone in Flyte's continued expansion into professional sports, aligning the Company's regional aviation platform with the travel needs of elite athletes who regularly navigate demanding schedules across multiple markets throughout the year.

    Professional athletes often rely on efficient regional transportation to maximize their time between tournaments, training, media obligations, and personal commitments. Through this partnership, Flyte will showcase how its growing fleet of Cirrus Vision Jets can provide a faster, more flexible alternative to traditional travel options for short-haul regional routes.

    "We are incredibly excited to begin this partnership with GSE Worldwide and Emiliano Grillo during one of golf's most prestigious events," said Marc Sellouk, Chief Executive Officer of Flyte. "Regional travel is a fundamental part of an athlete's lifestyle, and it’s exactly the problem Flyte was built to solve. We believe this partnership is a natural fit and marks the beginning of what we expect will be a long-term relationship with both GSE and Emiliano."

    GSE Worldwide is one of the premier sports and entertainment agencies in the industry, representing a diverse roster of athletes, personalities, and brands across multiple sports. Through this collaboration, Flyte aims to further strengthen its presence within professional sports while introducing its regional air mobility platform to new audiences.

    "Partnering with organizations and individuals who share our commitment to performance, efficiency, and excellence is central to our growth strategy," added Sellouk. "We look forward to building meaningful relationships throughout the GSE network and supporting athletes with a travel experience designed around their schedules."

    The partnership launched at the 2026 U.S. Open and serves as the foundation for future collaborative opportunities between Flyte, GSE Worldwide, and Emiliano Grillo.

    About Flyte

    Flyte is a technology-enabled regional air mobility company operating a growing fleet of Cirrus Vision Jets. Focused on short-haul markets, Flyte provides a faster and more efficient alternative to traditional private aviation by connecting travelers across underserved regional routes. Flight operations are conducted through Flyte's wholly owned subsidiary, Ponderosa Air, LLC, an FAA-certified Part 135 air carrier.

    For more information, visit www.flyflyte.com.

            

    About GSE Worldwide

    GSE Worldwide is a leading sports and entertainment agency representing elite athletes, coaches, broadcasters, personalities, and brands across golf, football, basketball, media, and entertainment. The agency provides comprehensive talent representation, brand partnerships, marketing, content, and business development services, helping clients maximize opportunities both on and off the field of play. Through its extensive network and industry relationships, GSE Worldwide has established itself as a trusted partner for some of the most recognizable names in sports and entertainment.

    For more information, visit www.gseworldwide.com.

    CONTACTS:

    Investor Relations

    973-691-2000

    IR@catheterprecision.com

    Media Relations

    Flyte@elev8newmedia.com

    # # #



    Primary Logo

    Get the next $VTAK alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $VTAK

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $VTAK
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Creatd Files Form S-1, Reports First Quarter 2026 Results and Updates Annual Meeting Schedule

    First Quarter Results Filed: Creatd filed its Quarterly Report for the period ended March 31, 2026, reviewed by the Company's PCAOB-registered independent auditors, highlighting significant balance sheet developments following the disposition of Flyte.SEC Registration Progress: The Company has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission as part of its initiative to re-establish SEC reporting status.Annual Meeting Update: Creatd has revised the record date for its annual shareholder meeting to Friday, June 26, 2026, and the meeting date to Monday, August 3, 2026. Shareholders of record as of June 26, 2026, will be entitled to vote at the meeting

    6/23/26 9:15:00 AM ET
    $CRTD
    $VTAK
    Publishing
    Consumer Discretionary
    Medical/Dental Instruments
    Health Care

    Flyte Partners with GSE Worldwide and PGA TOUR Professional Emiliano Grillo, Debuted at the 2026 U.S. Open

    Partnership positions Flyte within elite professional sports ecosystem through leading talent agency GSE Worldwide Collaboration highlights growing demand for efficient regional travel solutions among professional athletes FORT MILL, S.C., June 22, 2026 (GLOBE NEWSWIRE) -- Flyte, the rapidly growing Regional Air Mobility subsidiary of Catheter Precision, Inc. (NYSE:VTAK), today announced a partnership with sports and entertainment agency GSE Worldwide and PGA TOUR professional Emiliano Grillo that began this past weekend in the U.S. Open Championship. Grillo delivered an impressive performance at the 2026 U.S. Open, climbing as high as third place on the leaderboard during the champions

    6/22/26 4:15:00 PM ET
    $VTAK
    Medical/Dental Instruments
    Health Care

    Volato Closes $2.2 Million PIPE Priced at $0.34 Per Share

    Strategic investors support Volato’s AI-driven aviation strategy and next phase of growth across software-enabled operating platforms Volato Group, Inc. (NYSE:SOAR) ("Volato" or the "Company") today announced the closing of a $2.2 million private investment in public equity ("PIPE") financing priced at $0.34 per share. The financing strengthens Volato’s balance sheet and provides additional capital flexibility as the Company advances its AI-focused strategy, including the application of its artificial intelligence technology, aviation operating experience, and software development capabilities to private aviation and other software-enabled markets. Volato is also evaluating acquisition,

    6/22/26 9:00:00 AM ET
    $SOAR
    $VTAK
    Transportation Services
    Consumer Discretionary
    Medical/Dental Instruments
    Health Care

    $VTAK
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Jenkins David A

    4 - Catheter Precision, Inc. (0001716621) (Issuer)

    3/30/26 5:58:17 PM ET
    $VTAK
    Medical/Dental Instruments
    Health Care

    SEC Form 4 filed by Anderson Philip J

    4 - Catheter Precision, Inc. (0001716621) (Issuer)

    3/30/26 5:58:15 PM ET
    $VTAK
    Medical/Dental Instruments
    Health Care

    SEC Form 4 filed by Arno Andrew

    4 - Catheter Precision, Inc. (0001716621) (Issuer)

    3/30/26 5:58:11 PM ET
    $VTAK
    Medical/Dental Instruments
    Health Care

    $VTAK
    SEC Filings

    View All

    SEC Form S-1 filed by Catheter Precision Inc.

    S-1 - Catheter Precision, Inc. (0001716621) (Filer)

    6/22/26 4:20:25 PM ET
    $VTAK
    Medical/Dental Instruments
    Health Care

    Catheter Precision Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits

    8-K - Catheter Precision, Inc. (0001716621) (Filer)

    6/8/26 6:16:04 AM ET
    $VTAK
    Medical/Dental Instruments
    Health Care

    Catheter Precision Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - Catheter Precision, Inc. (0001716621) (Filer)

    5/18/26 4:17:11 PM ET
    $VTAK
    Medical/Dental Instruments
    Health Care

    $VTAK
    Leadership Updates

    Live Leadership Updates

    View All

    Catheter Precision, Inc. Announces New Chief Financial Officer

    FORT MILL, SC / ACCESSWIRE / January 7, 2025 / Catheter Precision, Inc. (NYSE:VTAK), a U.S.-based innovative medical device company focused on electrophysiology products, today announced that it has brought on board Philip Anderson, to take on the position of Chief Financial Officer. Margrit Thomassen, who has been our Interim Chief Financial Officer, will continue with the company in the role of Controller.David Jenkins, CEO of Catheter Precision, commented on the hire, "After some time of searching for the right fit, we are happy to have concluded our search with Phil Anderson joining the team. His background includes executive management across a variety of industries, managing hedge fund

    1/7/25 8:00:00 AM ET
    $VTAK
    Medical/Dental Instruments
    Health Care

    Catheter Precision, Inc. (NYSE American:VTAK) Presenting at the Sequire Investor Summit in Puerto Rico

    FORT MILL, SC / ACCESSWIRE / January 22, 2024 / Catheter Precision, Inc. (NYSE:VTAK), (the Company) a pioneering U.S. based medical device company committed to enhancing the well-being of patients with cardiac arrhythmias, is pleased to declare its participation in the forthcoming Sequire Investor Summit 2024. The eagerly awaited event, slated for January 23-25, 2024, at the Condado Vanderbilt Hotel in San Juan, Puerto Rico, is poised to provide a spectrum of compelling opportunities for funds, companies, and investors.Puerto Rico has become a hub for family offices, funds, and affluent investors, thanks to its advantageous tax benefits. It stands out as one of the rare locations globally wh

    1/22/24 8:00:00 AM ET
    $VTAK
    Medical/Dental Instruments
    Health Care

    $VTAK
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Catheter Precision Inc.

    SC 13G/A - Catheter Precision, Inc. (0001716621) (Subject)

    11/14/24 5:12:56 PM ET
    $VTAK
    Medical/Dental Instruments
    Health Care

    Amendment: SEC Form SC 13G/A filed by Catheter Precision Inc.

    SC 13G/A - Catheter Precision, Inc. (0001716621) (Subject)

    11/13/24 11:14:58 AM ET
    $VTAK
    Medical/Dental Instruments
    Health Care

    Amendment: SEC Form SC 13D/A filed by Catheter Precision Inc.

    SC 13D/A - Catheter Precision, Inc. (0001716621) (Subject)

    10/30/24 5:26:20 PM ET
    $VTAK
    Medical/Dental Instruments
    Health Care

    $VTAK
    Financials

    Live finance-specific insights

    View All

    Catheter Precision Reports 2025 Results and Updates on Strategic Expansion

    Clinical, Commercial and Regulatory Milestones Achieved in 2025 Establish a Strong Foundation in Life Sciences as Revenue Increases 95% Year Over Year Acquisition of Flyte and Strengthened Capital Position Unlock Multi-Segment Growth Strategy with Multiple Near-Term Catalysts FORT MILL, S.C., March 31, 2026 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (NYSE:VTAK) ("VTAK" or the "Company"), a U.S.-based innovative medical device company focused on electrophysiology products, today announced its financial results and operational update for the fourth quarter and full year ended December 31, 2025 as well as certain other business updates. 2025: Execution Across Clin

    3/31/26 8:00:00 AM ET
    $VTAK
    Medical/Dental Instruments
    Health Care

    CRTD (Creatd Inc.) Sells Remaining 80% of Fly Flyte to NYSE-Listed VTAK (Catheter Precision Inc.), Securing Significant Cash and Equity Position

    NEW YORK, March 10, 2026 (GLOBE NEWSWIRE) -- Creatd, Inc. (OTCQB:CRTDD) today announced that it has sold its remaining 80% equity stake in its subsidiary, Fly Flyte, Inc. ("Flyte"), to Catheter Precision, Inc. (NYSE:VTAK). Under the terms of the completed transaction, Creatd will receive approximately $6,000,000 in cash and nearly $6,000,000 in Convertible Preferred Stock of VTAK. The NYSE-approved transaction considerably strengthens Creatd's balance sheet. The sale is consistent with Creatd's strategy of developing turnkey operating solutions that prepare businesses for listing on the public markets while simultaneously retaining a minority interest in them. The transaction positions Cr

    3/10/26 8:00:00 AM ET
    $VTAK
    Medical/Dental Instruments
    Health Care

    VTAK Acquires 20% Interest in Creatd's Subsidiary Fly Flyte, Inc.

    Strategic Partnership: Creatd expanded Fly Flyte's investor network by adding NYSE-listed VTAK as an investor in its subsidiary.Portfolio Expansion: Creatd continues advancing its portfolio strategy through multiple active acquisition discussions.Innovation in Aviation: Fly Flyte, Inc. is transforming regional aviation through accessibility, convenience, and technology-driven operations. NEW YORK, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Creatd, Inc. (OTCQB:CRTD) announced that Catheter Precision, Inc. (NYSE:VTAK) has acquired a 20% equity interest in Fly Flyte, Inc., its subsidiary, through a secondary purchase from an existing shareholder. The transaction aligns with Creatd's strategy of nurtu

    2/17/26 2:17:42 PM ET
    $CRTD
    $VTAK
    Publishing
    Consumer Discretionary
    Medical/Dental Instruments
    Health Care